Innovative Industrial Properties Inc Aktie News

Cannabis stocks may be some of the most controversial investment ideas. But they are also turning out to be one of the most profitable.

SAN DIEGO--(BUSINESS WIRE)--Innovative Industrial Properties, Inc. (NYSE: IIPR) announced today it will report results for its first quarter ended March 31, 2024 after the market closes on Wednesday, May 8, 2024. Alan Gold, Executive Chairman, Paul Smithers, President and Chief Executive Officer, David Smith, Chief Financial Officer, Catherine Hastings, Chief Operating Officer, and Ben Regin, C...

The progress toward legalization of cannabis in the United States continues at a slow pace, but medical marijuana is now permitted in approximately 37 states. Germany recently became the latest country to legalize cannabis for personal use beginning in April, coinciding with the informal holiday of 4/20.

Dividend stocks are your best friend if you're looking to compound your money safely without worrying about the massive downside risk that often comes with buying into high-flying tech or growth stocks. However, not all dividend payers are boring old companies with no potential for capital appreciation.

The best marijuana stocks have been put through the wringer for years. But with U.S. cannabis sales on the rise, these picks could finally have their day in the sun.

Dividend growth stocks can provide reliable cash flows and help to build long-term wealth for income investors. Every month, we look at screening dividend stocks based on safety, growth, and consistency, which can help identify worthwhile investments. We look at a list of 25 of the top yielding based on these metrics, then take a quick look at the 5 of these top positions.

Smart investors always search for underutilized prospects with room to expand and provide stability. Here, you'll find three of these undiscovered gems.

Cannabis real estate investment trusts (REIT) could see higher highs on a few key catalysts.  For one, hedge fund manager Dougie Kass of Seabreeze Capital recently said the Food and Drug Administration (FDA) would soon reschedule cannabis to a less restrictive category.